Prescription drug · NDA AUTHORIZED GENERIC
Apraclonidine NDC 61314-665
Apraclonidine hydrochloride 5.75 mg/mL · Solution · Ophthalmic · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61314-665-05 | 61314066505 | 5 mL in 1 BOTTLE (61314-665-05)Marketed from Jul 19, 2009 | |
| 61314-665-10 | 61314066510 | 10 mL in 1 BOTTLE (61314-665-10)Marketed from Jul 19, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Apraclonidine
- Generic name (nonproprietary)
- apraclonidine
- Active ingredients
- Apraclonidine hydrochloride — 5.75 mg/mL
- Dosage form
- Solution
- Route
- Ophthalmic
- Labeler
- Sandoz IncNDC labeler code 61314
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 020258
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Agonists (Mechanism)
- Identifiers
- Product ID 61314-665_238af96f-2f89-9af4-e063-6394a90a9516SPL ID 238af96f-2f89-9af4-e063-6394a90a9516SPL set ID 04ad82af-e7ba-4f40-a120-be9d33cf0c7bRxCUI 308345UNII D2VW67N38HUPC 0361314665058, 0361314665102
- Pharmacologic class
- alpha-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N461314066505followed by a unit qualifier and the quantityPackage 61314-0665-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Apraclonidine ophthalmic solution 0.5% is indicated for short-term adjunctive therapy, in patients on maximally tolerated medical therapy, who require additional IOP reduction. Patients on maximally tolerated medical therapy, who are treated with apraclonidine ophthalmic solution 0.5% to delay surgery, should have frequent follow-up examinations and treatment should be discontinued if the IOP rises significantly. The addition of apraclonidine ophthalmic solution 0.5% to patients already using two aqueous suppressing drugs (i.e., beta-blocker plus carbonic anhydrase inhibitor) as part of their maximally tolerated medical therapy may not provide additional benefit. This i…
Excerpt only. Read the full label for complete information.
About NDC 61314-665
- What is NDC 61314-665?
- 61314-665 is the product NDC for Apraclonidine, Apraclonidine hydrochloride 5.75 mg/mL solution, listed with the FDA by Sandoz Inc. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Apraclonidine.
- What is the active ingredient?
- Apraclonidine hydrochloride.
- Who is the labeler?
- Sandoz Inc, NDC labeler code 61314. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Apraclonidine?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.